» Articles » PMID: 26706565

Polymeric Nanoparticles for Targeted Drug Delivery System for Cancer Therapy

Overview
Publisher Elsevier
Date 2015 Dec 27
PMID 26706565
Citations 147
Authors
Affiliations
Soon will be listed here.
Abstract

A targeted delivery system based on the polymeric nanoparticles as a drug carrier represents a marvelous avenue for cancer therapy. The pivotal characteristics of this system include biodegradability, biocompatibility, non-toxicity, prolonged circulation and a wide payload spectrum of a therapeutic agent. Other outstanding features are their distinctive size and shape properties for tissue penetration via an active and passive targeting, specific cellular/subcellular trafficking pathways and facile control of cargo release by sophisticated material engineering. In this review, the current implications of encapsulation of anticancer agents within polyhydroxyalkanoates, poly-(lactic-co-glycolic acid) and cyclodextrin based nanoparticles to precisely target the tumor site, i.e., cell, tissue and organ are highlighted. Furthermore, the promising perspectives in this emerging field are discussed.

Citing Articles

Magnetic Polymeric Conduits in Biomedical Applications.

Ganguly S, Margel S Micromachines (Basel). 2025; 16(2).

PMID: 40047623 PMC: 11857720. DOI: 10.3390/mi16020174.


Nanotherapeutic smart approaches for combating Alzheimer's disease and overcoming existing obstacles: A novel eco-friendly green approach.

Almehdi A, Aboubaker D, Hamdy R, El-Keblawy A Toxicol Rep. 2025; 14:101906.

PMID: 39926413 PMC: 11803169. DOI: 10.1016/j.toxrep.2025.101906.


Nanocarrier-mediated cancer therapy with cisplatin: .

Ranasinghe R, Mathai M, Alshawsh M, Zulli A Heliyon. 2025; 10(7):e28171.

PMID: 39839154 PMC: 11747978. DOI: 10.1016/j.heliyon.2024.e28171.


Pullulan nanoparticles inhibit the pathogenicity of by regulating hypha-related gene expression.

Hong S, Kim S, Chung C, Yun C, Lee J, Cho C Microbiol Spectr. 2024; :e0104824.

PMID: 39540747 PMC: 11619324. DOI: 10.1128/spectrum.01048-24.


Nanomaterials in Targeting Cancer Cells with Nanotherapeutics: Transitioning Towards Responsive Systems.

Jain B, Verma D, Rawat R, Berdimurodov E Curr Pharm Des. 2024; 30(38):3018-3037.

PMID: 39143881 DOI: 10.2174/0113816128317407240724065912.